Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group

The original article [1] contains an omission of information in the Financial support sub-section of the Declarations section. The authors would like to acknowledge the Andrew McDonough B+ Foundation for financial support of co-author Dr Yi-Cheng Wang throughout this study, and regret this inadverte...

Full description

Saved in:
Bibliographic Details
Published inJournal of hematology and oncology Vol. 9; no. 1; p. 133
Main Authors Laszlo, George S, Alonzo, Todd A, Gudgeon, Chelsea J, Harrington, Kimberly H, Kentsis, Alex, Gerbing, Robert B, Wang, Yi-Cheng, Ries, Rhonda E, Raimondi, Susana C, Hirsch, Betsy A, Gamis, Alan S, Meshinchi, Soheil, Walter, Roland B
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 30.11.2016
BioMed Central
BMC
Subjects
Erratum
Online AccessGet full text

Cover

More Information
Summary:The original article [1] contains an omission of information in the Financial support sub-section of the Declarations section. The authors would like to acknowledge the Andrew McDonough B+ Foundation for financial support of co-author Dr Yi-Cheng Wang throughout this study, and regret this inadvertent omission from the original publication.
Bibliography:correction
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
ISSN:1756-8722
1756-8722
DOI:10.1186/s13045-016-0364-0